Implant delivery system with marker interlock

US9597212B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9597212-B2
Application numberUS-201414180644-A
CountryUS
Kind codeB2
Filing dateFeb 14, 2014
Priority dateNov 1, 2002
Publication dateMar 21, 2017
Grant dateMar 21, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An implant delivery system is disclosed. The delivery system includes an elongated member having an implant mounting location. A self-expandable implant is mounted at the implant mounting location. The implant is held in a compressed orientation by a retractable sheath. An interlock structure prevents the implant from deploying prematurely as the sheath is retracted. The interlock structure includes radio-opaque markers that identify the position of the implant.

First claim

Opening claim text (preview).

What is claimed is: 1. A medical device, comprising: an implant including a plurality of struts having terminal ends on opposite ends of the implant, wherein at each end of the opposite ends of the implant, a respective first interlock structure including an enlargement projects outwardly from at least one of the terminal ends on the respective end of the implant; and an implant delivery system including: an elongate member including second interlock structures, the second interlock structures each being configured to couple with a respective one of the first interlock structures, the second interlock structures including a first set of second interlock structures configured to couple with first interlock structures on one end of the implant and a second set of second interlock structures configured to couple with first interlock structures on the other end of the implant, at least one of the second interlock structures including a receptacle dimensioned to receive the enlargement of the respective first interlock structure such that an outer periphery of the enlargement is disposed at least partially within the receptacle; and a retractable sheath configured to substantially surround at least a portion of at least one of the first interlock structures and at least a portion of a respective one of the second interlock structures to keep the at least one of the first interlock structures and the respective one of the second interlock structures engaged to prevent release of the implant while the retractable sheath is substantially surrounding the at least the portion of the at least one of the first interlock structures and the at least the portion of the respective one of the second interlock structures. 2. The medical device according to claim 1 wherein a plurality of the terminal ends of the struts each includes a respective first interlock structure comprising a respective radiopaque marker. 3. The medical device according to claim 2 wherein each end of the implant includes a plurality of the first interlock structures each dimensioned to couple with a respective second interlock structure of the elongate member. 4. The medical device according to claim 1 wherein the implant is positioned over the elongate member proximal to a distal end of the elongate member. 5. The medical device according to claim 4 wherein the distal end of the elongate member includes a tapered and flexible distal tip member. 6. The medical device according to claim 1 further comprising at least one radiopaque marker attached to at least one of the first interlock structures. 7. The medical device according to claim 6 wherein the at least one radiopaque marker is attached to the at least one of the first interlock structures by at least one of an adhesive, heat fusion, interference fit, a fastener, or an intermediate member. 8. The medical device according to claim 1 wherein at least some of the first interlock structures comprise a radiopaque marker and at least one of the radiopaque markers is made from a material having greater radiopacity than the material forming the plurality of struts. 9. The medical device according to claim 1 , wherein at least some of the first interlock structures comprise a radiopaque marker and at least one of the radiopaque markers is made from at least one of tantalum, platinum, gold, tungsten, or alloys thereof. 10. The medical device according to claim 1 wherein each first interlock structure comprises a radiopaque marker. 11. The medical device according to claim 1 wherein the implant is a self-expanding implant. 12. A medical device, comprising: an implant including a plurality of struts having terminal ends on opposite ends of the implant, wherein at each end of the opposite ends of the implant, a respective first interlock structure including an enlargement projects outwardly from at least one of the terminal ends on the respective end of the implant; and an implant delivery system including: an elongate member defining a longitudinal axis and including second interlock structures, the second interlock structures each dimensioned to couple with respective first interlock structures of radially adjacent terminal ends of the implant, the second interlock structures including a first set of second interlock structures configured to couple with first interlock structures on a first end of the opposite ends of the implant and a second set of second interlock structures configured to couple with first interlock structures on a second end of the opposite ends of the implant, at least one of the second interlock structures including a receptacle dimensioned to receive the first interlock structures of the radially adjacent terminal ends of the implant such that outer peripheries of the enlargements of the first interlock structures are disposed at least partially within the receptacle; and a retractable sheath configured to substantially surround at least a portion of the first interlock structures of radially adjacent terminal ends and at least a portion of a respective one of the second interlock structures to keep the first interlock structures of radially adjacent terminal ends and the respective one of the second interlock structures engaged to prevent release of the implant while the retractable sheath is substantially surrounding the at least the portion of the first interlock structures of radially adjacent terminal ends and the at least the portion of the respective one of the second interlock structures. 13. The medical device according to claim 12 wherein the implant is positioned over the elongate member proximal to a distal end of the elongate member. 14. The medical device according to claim 13 wherein the distal end of the elongate member includes a tapered and flexible distal tip member. 15. The medical device according to claim 12 further comprising at least one radiopaque marker attached to a respective first interlock structure. 16. The medical device according to claim 15 wherein each radiopaque marker is attached to the respective first interlock structure by at least one of an adhesive, heat fusion, interference fit, a fastener, or an intermediate member. 17. The medical device according to claim 12 wherein at least some of the first interlock structures comprise a radiopaque marker and each radiopaque marker is made from a material having greater radiopacity than the material forming the plurality of struts. 18. The medical device according to claim 12 , wherein at least some of the first interlock structures comprise a radiopaque marker and each radiopaque marker is made from at least one of tantalum, platinum, gold, tungsten, or alloys thereof. 19. The medical device according to claim 12 wherein each of the terminal ends on each of the opposite ends of the implant each includes the respective first interlock structure comprising a radiopaque marker.

Assignees

Inventors

Classifications

  • Means for mounting a stent or stent-graft onto or into a placement instrument · CPC title

  • Locking connectors, e.g. using male-female connections · CPC title

  • radio-opaque, e.g. radio-opaque markers · CPC title

  • Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve · CPC title

  • Adjacent bands are arranged out of phase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9597212B2 cover?
An implant delivery system is disclosed. The delivery system includes an elongated member having an implant mounting location. A self-expandable implant is mounted at the implant mounting location. The implant is held in a compressed orientation by a retractable sheath. An interlock structure prevents the implant from deploying prematurely as the sheath is retracted. The interlock structure inc…
Who is the assignee on this patent?
Covidien Lp
What technology area does this patent fall under?
Primary CPC classification A61F2/95. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).